GRaPH-Int

Last updated
GRaPH-Int Logo GraphInt logo.png
GRaPH-Int Logo

The Genome-based Research and Population Health International Network (GRaPH-Int) is an international collaboration of experts and researchers focused in the area of population health. The principal goal of the network is to promote the translation of genome-based science and technology into improvements in population health.

Contents

One of GRaPH-Int's key features is the integration of knowledge from a range of disciplines, such as genome-based science, population sciences, the humanities and social sciences. The ‘Int’ underscores the interdisciplinarity of the collaboration, but also signifies that it is international and integrated.

Mission

The mission of the Genome-based Research and Population Health International Network (GRaPH-Int) is to promote an international collaboration that facilitates the responsible and effective integration of genome-based knowledge and technologies into public policies, programmes, and services for improving population health.[ citation needed ]

History

Bellagio Initiative

Modern research in genetics and molecular biology, boosted by information emerging from the Human Genome Project, offers new opportunities for the promotion of population health. Anticipated benefits include more effective population-based public health disease prevention and control activities; population screening and predictive genetic testing for common multi-factorial diseases; and targeted populations-based interventions. [1]

However, mining the genome-based information for potential benefits and ensuring that they are effectively implemented, with appropriate attention to avoiding harm, has proven to be an enormous task. A new field within public health, called public health genomics has evolved which addresses these issues. [2] [3]

A meeting of experts was convened in Bellagio Italy in 2005 with funding from the Rockefeller Foundation to address the tasks involved in deriving public health benefit from this vast array of new knowledge. The delegates saw the need for an international network, which would promote the goals of public health genomics. Based on discussions of the challenges involved, they developed the framework and priorities of the Genome-based Research and Population Health International Network (GRaPH-Int). The Bellagio group defined GRaPH-Int as a network of individuals who are interested in the impact of the interaction between genes and the environment on population health [4]

Following the Bellagio meeting, The GRaPH-Int website was launched at the 4th International DNA Sampling Conference - Montreal, June 2006.[ citation needed ]

Goals

GRaPH-Int aims to establish itself as an international network that promotes the goals of public health, engages international experts, and shares knowledge and resources. The following six goals have identified for the network:[ citation needed ]

Enterprise

The GRaPH-Int Enterprise was developed and introduced at the Bellagio workshop as a conceptual and systematic description of the flow of information. It describes the process of translating genome-based science and technology into improvements in population health.[ citation needed ]

Bioportal

The recent overload of information on public health genome-based science necessitates the creation of an international search engine to link policymakers, researchers and public health professionals to national policy statements, epidemiological data, public health, news and events. GRaPH-Int has undertaken the task of developing this service, and the first phase of development began in 2007.[ citation needed ]

This search engine, referred to as the Bioportal, will optimize searches on:

Governance

GRaPH-Int and its activity are overseen by an administrative hub, secretariat, executive committee and a steering committee.

The administrative hub

The GRaPH-Int Administrative Hub is located in Canada and is funded by the Public Health Agency of Canada (PHAC). A major component of the Administrative Hub is the secretariat (managed by the Centre de recherche en droit public), whose services better enable PHAC, as the designated administrative hub for the network.[ citation needed ]

Executive committee

The purpose of the GRaPH-Int Executive Committee is to provide leadership in fulfilling the mission and goals of GRaPH-Int. The founding Executive Committee members are Ron Zimmern, Public Health Genetics Unit (PHGU) now the PHG Foundation, Cambridge, UK, Wylie Burke, Institute for Public Health Genetics (IPHG) and Department of Medical History and Ethics, University of Washington, Seattle, U.S.A., Muin Khoury, National Office of Public Health Genomics (NOPHG), Centers for Disease Control and Prevention, Atlanta, U.S.A., Mohamed Karmali, Laboratory for Foodborne Zoonoses, and Office of Biotechnology, Genomics & Population Health, Public Health Agency of Canada, and Professor Julian Little, Canada Research Chair in Human Genome Epidemiology, University of Ottawa.[ citation needed ]

Steering committee

The purpose of the GRaPH-Int Steering Committee is to support the GRaPH-Int Executive Committee in their mission. The steering committee is composed of network participants in a mixture that will adequately represent the different institutional, scientific disciplines and perspectives necessary to address the mission and goals of GRaPH-Int. The Founder Chairman of the steering committee is Ron Zimmern.[ citation needed ]

The steering committee elects the following officers: chairperson, vice-chairperson, and secretary. The chairperson, vice-chairperson, the past-chairperson, secretary, and the executive director constitute the executive committee. The founding executive committee members include:[ citation needed ]

Executive director, PHG Foundation, Cambridge, UK

Director-general, Laboratory for Foodborne Zoonoses, Office of Biotechnology, Genomics & Population Health Public Health Agency of Canada, Ontario, Canada

Department of Medical History and Ethics University of Washington, Seattle, USA

Founding organizations

The following entities are recognized as GraPH-Int founding organizations:

Membership

Organizational participation in GRaPH-Int is open to new members throughout the world that have an interest in the development and use of genome-based knowledge and technologies for the benefit of population health.

Related Research Articles

<span class="mw-page-title-main">Marco Marra</span> Canadian geneticist

Marco A. Marra is a Distinguished Scientist and Director of Canada's Michael Smith Genome Sciences Centre at the BC Cancer Research Centre and Professor of Medical Genetics at the University of British Columbia (UBC). He also serves as UBC Canada Research Chair in Genome Science for the Canadian Institutes of Health Research and is an inductee in the Canadian Medical Hall of Fame. Marra has been instrumental in bringing genome science to Canada by demonstrating the pivotal role that genomics can play in human health and disease research.

The Human Genome Organisation (HUGO) is a non-profit organization founded in 1988. HUGO represents an international coordinating scientific body in response to initiatives such as the Human Genome Project. HUGO has four active committees, including the HUGO Gene Nomenclature Committee (HGNC), and the HUGO Committee on Ethics, Law and Society (CELS).

<span class="mw-page-title-main">Wellcome Sanger Institute</span> British genomics research institute

The Wellcome Sanger Institute, previously known as The Sanger Centre and Wellcome Trust Sanger Institute, is a non-profit British genomics and genetics research institute, primarily funded by the Wellcome Trust.

<span class="mw-page-title-main">Bartha Knoppers</span> Canadian lawyer and scientist

Bartha Maria Knoppers, OC OQ is a Canadian law Professor and an expert on the ethical aspects of genetics, genomics and biotechnology.

Public health genomics is the use of genomics information to benefit public health. This is visualized as more effective preventive care and disease treatments with better specificity, tailored to the genetic makeup of each patient. According to the Centers for Disease Control and Prevention (U.S.), Public Health genomics is an emerging field of study that assesses the impact of genes and their interaction with behavior, diet and the environment on the population's health.

Personal genomics or consumer genetics is the branch of genomics concerned with the sequencing, analysis and interpretation of the genome of an individual. The genotyping stage employs different techniques, including single-nucleotide polymorphism (SNP) analysis chips, or partial or full genome sequencing. Once the genotypes are known, the individual's variations can be compared with the published literature to determine likelihood of trait expression, ancestry inference and disease risk.

The Centre of Genomics and Policy is affiliated with McGill University and the Genome Innovation Centre Canada. The Centre was launched to respond to the urgent need for informed public policy and analyses on socio-ethical issues related to human genetics research at the international, national, and provincial levels. Its website provides policy makers and the public access to policy statements concerning genetic research.

<span class="mw-page-title-main">Stephen W. Scherer</span> Canadian scientist (born 1964)

Stephen Wayne "Steve" Scherer is a Canadian scientist who studies genetic variation in human disease. He obtained his PhD at the University of Toronto under Professor Lap-chee Tsui. Together they founded Canada's first human genome centre, the Centre for Applied Genomics (TCAG) at the Hospital for Sick Children. He continues to serve as director of TCAG, and is also a University Professor in the Department of Molecular Genetics, and the director of the McLaughlin Centre at the Temerty Faculty of Medicine at the University of Toronto.

<span class="mw-page-title-main">John Quackenbush</span> American bioinformatician

John Quackenbush is an American computational biologist and genome scientist. He is a professor of biostatistics and computational biology and a professor of cancer biology at the Dana–Farber Cancer Institute (DFCI), as well as the director of its Center for Cancer Computational Biology (CCCB). Quackenbush also holds an appointment as a professor of computational biology and bioinformatics in the Department of Biostatistics at the Harvard School of Public Health.

<span class="mw-page-title-main">Robert C. Green</span> American geneticist

Robert C. Green is an American medical geneticist, physician, and public health researcher. He directs the Genomes2People Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women's Hospital and the Broad Institute, and is Director of the Preventive Genomics Clinic at Brigham and Women's Hospital. Research led by Green includes clinical and research aspects of genomic and precision medicine, including the development and disclosure of Alzheimer's disease risk estimates and one of the first prospective studies of direct-to-consumer genetic testing services. He has studied the implementation of medical sequencing in healthy adults, newborns, and active duty military personnel. As of 2020, he is leading the first research collaboration to explore return of genomic results and better understand penetrance in a population-based cohort of underrepresented minorities. He has led the Preventive Genomics Clinic at Brigham and Women's Hospital since its creation in 2019.

<span class="mw-page-title-main">Andres Metspalu</span> Estonian geneticist

Andres Metspalu is an Estonian geneticist and member of the Estonian Academy of Sciences.

<span class="mw-page-title-main">Eric Schadt</span> American scientist

Eric Emil Schadt is an American mathematician and computational biologist. He is founder and former chief executive officer of Sema4, a patient-centered health intelligence company, and dean for precision medicine and Mount Sinai Professor in Predictive Health and Computational Biology at the Icahn School of Medicine at Mount Sinai. He was previously founding director of the Icahn Institute for Genomics and Multiscale Biology and chair of the Department of Genetics and Genomics Sciences at the Icahn School of Medicine at Mount Sinai.

Genetics nursing is a nursing specialty that focuses on providing genetic healthcare to patients.

<span class="mw-page-title-main">Gerardo Jiménez Sánchez</span>

Gerardo Jiménez Sánchez is a Mexican-born pediatrician, scientist and businessman. Along with David Valle and Barton Childs, he completed the first medical analysis of the human genome. He was founder and director of the first National Institute of Genomic Medicine in Latin America (INMEGEN) and leader of the team that developed the Genomic Map of the mexican population.

The Global Alliance for Genomics and Health (GA4GH) is an international consortium that is developing standards for responsibly collecting, storing, analyzing, and sharing genomic data in order to enable an "internet of genomics". GA4GH was founded in 2013.

The Genome News Network is an online magazine that publishes news articles and educational resources about genomics and medicine. It was founded in 1999, with Barbara Culliton as the founding editor-in-chief. It was originally published by Celera Genomics. In 2001, the Institute for Genomic Research became the magazine's new publisher. An article published in the Lancet Oncology that year stated that the magazine "...offers news, original articles, the online reference book, What’s a genome?, and primers on sequencing and assembling the genome – all well written and illustrated". As of 2010, new issues of the magazine were published biweekly.

Muin Joseph Khoury is an American geneticist and epidemiologist who conducts research in the field of public health genomics. He is the founding director of the Office of Public Health Genomics at the Centers for Disease Control and Prevention since 1997. He has also been a senior advisor in public health genomics at the National Cancer Institute since 2007.

Eric M. Meslin PhD FRSC FCAHS is a Canadian-American philosopher-bioethicist and current President and CEO of the Council of Canadian Academies (CCA).

Misaki Wayengera is a Ugandan physician, academician, and a medical researcher. He serves as a lecturer for Pathology, Immunology and Molecular Biology at Makerere University College of Health Sciences. He is the chairperson of Uganda's Scientific Advisory Committee on COVID-19 for the Ministry of Health and the National Task Force.

<span class="mw-page-title-main">Wylie Burke</span> American geneticist

Wylie Burke is a Professor Emerita and former Chair of the Department of Bioethics and Humanities at the University of Washington and a founding co-director of the Northwest-Alaska Pharmacogenomics Research Network, which partners with underserved populations in the Pacific Northwest and Alaska.

References

  1. Collins, FS (1999). "Shattuck lecture – medical and societal consequences of the Human Genome Project". The New England Journal of Medicine. 34 (1): 28–37. doi: 10.1056/NEJM199907013410106 . PMID   10387940.
  2. Khoury, MJ; W Burke; EJ Thompson (2000). Genetics and public health in the 21st century. Oxford University Press.
  3. Stewart, A; P Brice; H Burton; P Pharaoh; S Sanderson; R Zimmern (2007). Genetics, Health Care and Public Policy. An Introduction to Public Health Genetics. Cambridge University Press.
  4. Burke, W; MJ Khoury; A Stewart; RL Zimmern (July 2006). "Bellagio Group. The path from genome-based research to population health: development of an international public health genomics network". Genetics in Medicine. 8 (7): 451–458. doi: 10.1097/01.gim.0000228213.72256.8c . PMID   16845279. S2CID   863513.